Alignment Healthcare Inc. Common Stock (ALHC)
Stock · NASDAQ · Health Care
$8.3as of 10/16/2026
Price chart
Active signals
Revenue-Price Divergence (6M)75.2%Revenue-Price Divergence (1Y+)75.2%RSI Positive Divergence36.2%200 SMA Touch0.0%
Resistance level
$13.38
Industry
Medical Specialities
ALHC Signal Track Record
How signals performed across all stocks →What ALHC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 44 | +0.6% | 52% | September 15, 2026 |
| Bollinger Band Breakout | 22 | +1.4% | 59% | June 9, 2026 |
| Bollinger Band Breakdown | 21 | -0.1% | 43% | September 11, 2026 |
| 200-Day Moving Average TouchActive now | 13 | -6.6% | 23% | July 24, 2026 |
| Any 20-session window (baseline) | +0.7% | 51% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ALHC
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.
- Sector
- Health Care
- Industry
- Medical Specialities
- Employees
- 1,849
- Website
- www.alignmenthealth.com/
Fundamentals
- 1-day range
- $8.02$8.37
- Market cap
- $2.78B
- P/E (trailing)
- 41.54
- P/E (forward)
- 12.74
- EPS (trailing)
- $0.19
- Dividend yield
- —
- Beta
- 1.04
- Avg. volume
- 8.31M
52-week range
$6.01$25.12
Next earnings: October 29, 2026 · EPS estimate $0.04After Closeconfirmed
How Alignment Healthcare Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 27, 2026 · via SEC EDGAR / Finnhub
Operating Income$14.75M(0%)
Forecasts
13 analyst ratings
Buy 85%
Hold 15%
Sell 0%
1-year price forecast
High
$26
+213.3%
Median
$11
+32.5%
Low
$9
+8.4%
Alignment Healthcare Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ALHCAlignment Healthcare Inc. Common Stock$8.28▲ 1.60%Market cap $2.78BP/E 41.54$6.01$25.12
- GRALGRAIL Inc. Common Stock$117.81▼ 13.03%Market cap $2.72BP/E —$41.5$166.48
- ACHCAcadia Healthcare Company Inc. Common Stock$29.98▼ 3.41%Market cap $2.86BP/E —$11.43$35.83
- CLOVClover Health Investments Corp. Class A Common Stock$4.48▼ 4.27%Market cap $2.45BP/E —$1.58$5.59
- CDNACareDx Inc. Common Stock$64▼ 4.01%Market cap $2.32BP/E 30.15$14.03$72.51
- VCYTVeracyte Inc. Common Stock$43.12▼ 2.86%Market cap $3.71BP/E 31.17$29.46$60.91
- FTREFortrea Holdings Inc. Common Stock$22.49▼ 1.12%Market cap $1.68BP/E —$8.55$23.51
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ALHC Alignment Healthcare Inc. Common Stock | $2.78B | 41.54 | $8.28 | ▲ 1.60% | $6.01$25.12 |
| GRAL GRAIL Inc. Common Stock | $2.72B | — | $117.81 | ▼ 13.03% | $41.5$166.48 |
| ACHC Acadia Healthcare Company Inc. Common Stock | $2.86B | — | $29.98 | ▼ 3.41% | $11.43$35.83 |
| CLOV Clover Health Investments Corp. Class A Common Stock | $2.45B | — | $4.48 | ▼ 4.27% | $1.58$5.59 |
| CDNA CareDx Inc. Common Stock | $2.32B | 30.15 | $64 | ▼ 4.01% | $14.03$72.51 |
| VCYT Veracyte Inc. Common Stock | $3.71B | 31.17 | $43.12 | ▼ 2.86% | $29.46$60.91 |
| FTRE Fortrea Holdings Inc. Common Stock | $1.68B | — | $22.49 | ▼ 1.12% | $8.55$23.51 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- UBS Maintains Neutral on Alignment Healthcare, Lowers Price Target to $9benzinga · 10/12/2026
- Why Alignment Healthcare (ALHC) Shares Are Trading Lower TodayYahoo · 10/9/2026
- Humana Stock Surges After Key Medicare Advantage Plan Gets Higher RatingYahoo · 10/9/2026
- Alignment Healthcare (ALHC) Is Up 12.5% After Mixed California Star Rating And Network Expansion NewsYahoo · 10/9/2026
- Alignment Healthcare (ALHC) Stock Looks Fairly Valued Despite Earnings QuestionsYahoo · 10/9/2026
- William Blair Downgrades Alignment Healthcare to Market PerformBenzinga · 10/9/2026
- JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $10Benzinga · 10/9/2026
- Gapping stocks in Friday's sessionChartMill · 10/9/2026
- Alignment Healthcare: CMS Ratings Exacerbate Its ChallengesSeekingAlpha · 10/9/2026
Insider Activity
Insider Actions →Acquired
239.8K
Disposed
1.59M
- Kim Hyong · October 6, 2026 · Sale32.5K @ $8.3
- KONOWIECKI JOSEPH S · September 17, 2026 · Sale23.5K @ $8.61
- KAO JOHN E · September 14, 2026 · Sale27.4K @ $13
- Maroney Dawn Christine · September 11, 2026 · Sale122.7K @ $12.68
- KAO JOHN E · September 11, 2026 · Sale385.3K @ $12.68
- KAO JOHN E · September 10, 2026 · Sale172.6K @ $12.96
- Maroney Dawn Christine · August 14, 2026 · Sale5.0K @ $14
- KAO JOHN E · August 10, 2026 · Sale298.0K @ $13.88
- Maroney Dawn Christine · July 15, 2026 · Option Exercise152.1K @ $9.06
- Maroney Dawn Christine · July 15, 2026 · Sale177.1K @ $20.83
- KAO JOHN E · July 10, 2026 · Sale18.4K @ $20.65
- KAO JOHN E · July 10, 2026 · Sale279.6K @ $19.81
- Hochradel Shane J. · July 1, 2026 · Grant87.7K
- KONOWIECKI JOSEPH S · July 1, 2026 · Sale25.0K @ $24
- KONOWIECKI JOSEPH S · June 26, 2026 · Sale25.0K @ $23
Institutional Ownership
March 31, 2026
- Total shares held
- 191.10M
- Total value held
- $3.02B
- Institutional holders
- 285
Top holders this quarter
- Unknown17.10M
- Unknown15.89M
- Unknown14.08M
- Unknown13.15M
- Unknown7.97M
- Unknown7.00M
- Unknown6.05M
- Unknown5.74M
- Unknown5.57M
- Unknown5.21M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
ALHC Faces Downgrade and Lower Target Amid Mixed CMS Ratings
Alignment Healthcare shares are trading lower after William Blair downgraded the stock to Market Perform and JP Morgan cut its price target to $10. These moves followed mixed California Star Ratings and news of network expansion, which analysts say highlight ongoing operational challenges. The stock is currently trading near its 52-week low, reflecting the negative sentiment from these recent analyst actions.
ALHC Faces Downgrade and Lower Target Amid Mixed CMS Ratings. Alignment Healthcare shares are trading lower after William Blair downgraded the stock to Market Perform and JP Morgan cut its price target to $10. These moves followed mixed California Star Ratings and news of network expansion, which analysts say highlight ongoing operational challenges. The stock is currently trading near its 52-week low, reflecting the negative sentiment from these recent analyst actions.